E220 - The role of oral antiviral therapies for acute COVID-19
Dhineli Perera speaks with infectious diseases physician Josh Davis about the management of acute COVID-19 in the community. They discuss the major risk factors for severe disease, the evidence behind...
12 Aug 25min
E219 - Sodium valproate: balancing benefits and risks especially in people of childbearing potential
Dhineli Perera talks to neurologist Dan McLaughlin about the benefits and risks with sodium valproate, especially in people of childbearing potential. Dan outlines the evolving landscape of valproate ...
20 Jul 23min
E218 - Diagnosis and management of irritable bowel syndrome
Laura Beaton speaks with gastroenterologist Nicholas Talley about his paper on the diagnosis and management of irritable bowel syndrome (IBS). Nick outlines the clinical features associated with IBS a...
6 Jul 28min
E217 - Emergency contraception: an overview
Jo Cheah talks to Jo Gross, consultant pharmacist, about her paper on emergency contraception. They discuss the types of emergency contraception available in Australia, factors that influence drug cho...
22 Jun 18min
E216 - Cardiovascular-kidney-metabolic (CKM) syndrome
Justin Coleman chats with nephrologist Karen Dwyer about her paper on cardiovascular-kidney-metabolic (CKM) syndrome. Karen outlines the underlying conditions, pathophysiology, and stages of progressi...
8 Jun 18min
E215 - Vitamin B12 deficiency: testing and treatment
David Liew speaks to haematologist Cecily Forsyth about her paper on vitamin B12 testing and treating deficiency. They discuss the causes, notable risk factors, and clinical signs and symptoms of B12 ...
25 Mai 21min
E214 - Therapeutic Guidelines Kidney and Urinary
Therapeutic Guidelines expert group member Lee Fong returns to the podcast to talk to Justin Coleman about the brand-new Kidney and Urinary guidelines. Focusing on GP management, the conversation cove...
11 Mai 19min
E213 - Metabolic dysfunction–associated fatty liver disease an update
Laura Beaton talks to hepatology research fellow Richard O'Halloran about his paper on metabolic dysfunction–associated fatty liver disease (MAFLD). Richard outlines risk factors and comorbidities t...
27 Apr 15min
